Skip to main content

Table 2 Patient demographics for the PREOPANC and LAPC datasets

From: Artificial intelligence for assessment of vascular involvement and tumor resectability on CT in patients with pancreatic cancer

Characteristic

PREOPANC dataset

N = 232

LAPC dataset

N = 50

Sex, n (%), female, male

57 (42), 79 (58)

76 (50.7), 74 (49.3)

Median age at diagnosis, years

66.1

64.4

Median tumor size, cm (dev)

3.02 (1.0)

4.3 (1.63)

Tumor location, n (%)

 Head

87 (68.5)

61 (48.8)

 Uncinate

15 (11.8)

23 (18.4)

 Body

11 (8.7)

29 (23.2)

 Tail

14 (11)

12 (9.6)

Resection margin, n (%), R0, R1

65 (47.8), 33 (24.3)

13 (8.6), 7 (4.6)

Neoadjuvant therapy, n (%)

 None

35 (26.7)

125 (83.7)

 FOLFIRINOX

32 (24.4)

25 (16.3)

 Gemcitabine + radiation

64 (48.9)

0 (0)

  1. dev, deviation; R0, radical resection; R1, non-radical resection; FOLFIRINOX, bolus and infusional 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin; Gemcitabine, 2′-deoxy-2′,2′-difluorocytidine monohydrochloride (β isomer)